LLY: 10% Owner Lilly Endowment Sells $479K in Stock
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
LLY: 10% Owner Lilly Endowment Sells $479K in Stock
Company: ELI LILLY & Co (LLY) Form: 4 | Filed: 2025-11-05 Significance: Low
Insider: LILLY ENDOWMENT INC Title: N/A | Relationship: 10% Owner
Transaction: • Type: Sale • Shares: 526 • Price: $910.72 • Value: $479,038 • Owned After: 93,931,452
Key Insight: A 10% owner made a very small, routine sale, representing a negligible fraction of its total holdings (0.0006%) and the company's market cap (0.00006%).
Market Context: This transaction is immaterial for a mega-cap pharmaceutical company like Eli Lilly. The insider remains a top shareholder with nearly 10% ownership post-transaction.
Comprehensive Analysis
SEC Filing Analysis: ELI LILLY & Co (LLY)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A 10% owner, Lilly Endowment Inc., executed a minor sale of approximately $479K in LLY stock, which is insignificant relative to its massive holding and the company's $811.66B market cap.
- Market Impact: Negligible. This transaction is considered routine and carries no significant market signal.
Company Information
| Field | Value |
|---|---|
| Company | ELI LILLY & Co |
| Ticker Symbol | LLY |
| CIK | 0000059478 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | LILLY ENDOWMENT INC |
| CIK | 0000316011 |
| Title/Position | N/A |
| Relationship | 10% Owner |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-04 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 526 |
| Price Per Share | $910.719 |
| Total Value | $479,038.19 |
| Shares Owned After | 93,931,452 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $479,038.19 |
| % of Market Cap | 0.00006% |
| Shares Transacted | 526 |
| % of Shares Outstanding | 0.00006% |
| Post-Transaction Ownership | 93,931,452 shares (9.92% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The ~$479K sale is trivial for an $811.66 billion mega-cap company like Eli Lilly.
- Ownership Concentration: Lilly Endowment remains a substantial shareholder, holding 9.92% of all outstanding shares even after this minor sale. The sale represented less than 0.001% of its total holdings.
- Transaction Significance: The transaction is statistically insignificant against all key metrics (% of market cap, % of shares outstanding, % of insider's holdings) and is considered routine.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is far too small to influence market perception or stock price. It is likely for portfolio rebalancing or liquidity purposes by the Endowment, not a change in outlook.
Volume & Sentiment
- Expected Volume Impact: None. The transaction size is a tiny fraction of the stock's typical daily trading volume.
- Sentiment Indicator: Neutral. The filing provides no bullish or bearish signal.
Additional Context
Transaction Notes
- Special Circumstances: The filing footnote indicates the price is a weighted average from multiple trades, which is common for institutional dispositions.
- Market Environment: This is a routine transaction that does not signal any change in the insider's long-term view of the company.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
